The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety;Die neuroendokrinologie von stress und die pathophysiologie und theraphie von depression und angst

Nervenarzt

Volumn 74, Issue 3, 2003, Pages 279-291

  Strohle A ^a,b  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Depression; Hypothalamic pituitary adrenocortical system; Panic disorder; Pathophysiology; Stress; Treatment

Indexed keywords

3 (6 DIMETHYLAMINO 4 METHYL 3 PYRIDINYL) 7 DIPROPYLAMINO 2,5 DIMETHYLPYRAZOLO[1,5 A]PYRIMIDINE; 3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; ANTIDEPRESSANT AGENT; ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR RECEPTOR; CORTICOSTEROID; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; DEXAMETHASONE; FLUOXETINE; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ANTAGONIST; HYDROCORTISONE; KETOCONAZOLE; LACTATE SODIUM; METYRAPONE; MIFEPRISTONE; MINERALOCORTICOID RECEPTOR; PROGESTERONE; STEROID HORMONE; UNCLASSIFIED DRUG;

ANXIETY DISORDER; DEXAMETHASONE SUPPRESSION TEST; ESCAPE BEHAVIOR; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; MENTAL STRESS; NEUROENDOCRINOLOGY; PANIC; PATHOPHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; REVIEW;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; AROUSAL; ATRIAL NATRIURETIC FACTOR; CORTICOTROPIN-RELEASING HORMONE; DEPRESSIVE DISORDER; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NEUROTRANSMITTER AGENTS; PANIC DISORDER; PITUITARY-ADRENAL SYSTEM; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; STRESS DISORDERS, POST-TRAUMATIC;

EID: 0037937443     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-002-1444-7     Document Type: Review

References (63)

1. Abelson JL, Curtis CG (1996) Hypothalamic-pituitary-adrenal axis activity in panic disorder-24-hour secretion of corticotropin and cortisol. Arch Gen Psychiatry 53:323-331
2. Bandelow B, Wedekind D, Pauls J, Broocks A, Hajak G, Rüther E (2000) Salivary cortisol in panic attacks. Am J Psychiatry 157:454-456
3. Belanoff JK, Gross K, Yager A, Schatzberg AF (2001) Corticosteroids and cognition. J Psychiatr Res 35:127-145
4. Bremner JD, Licinio J, Darwell A t al. (1997) Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry 154:624-629
5. Carroll BJ, Feinberg M, Greden JF (1981) A specific laboratory test for the diagnosis of melancholia. Arch Gen Psychiatry 38:15-22
6. Chalmers DT, Lowenberg TW, de Souza EB (1995) Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: Comparison with CRF1 receptor mRNA expression. J Neurosci 15:6340-6350
7. Curtis GC, Cameron OG, Neese RM (1982) The dexamethasone suppression test in panic disorder and agoraphobia. Am J Psychiatry 139:1043-1046
8. de Bold AJ (1985) Atrial natriuretic factor a hormone produced by the heart. Science 230:767-770
9. de Kloet ER (1991) Brain corticosteroid receptor balance and homeostatic control. Front Neuroendocrinol 12:95-164
10. Deuschle M, Schweiger U, Weber B et al. (1997) Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls. J Clin Endocrinol Metab 82:234-238
11. Duman RS, Heninger GR, Nestler EJ (1997) A molecular and cellular theory of depression. Arch Gen Psychiatry 54:597-606
12. Dunn AJ, Berridge CW (1990) Physiological and behavioral responses to corticotropin releasing factor administration: Is CRF a mediator of anxiety or stress response. Brain Res Rev 15:71-100
13. Geriacoti TD, Orth DN, Ekhator NN, Blumenkopf B, Loosen PT (1992) Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans. J Clin Endocrinol Metab 74:1325-1330
14. Griffin LD, Mellon SH (1999) Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc Natl Acad Sci 96:13512-13517
15. Heuser IJE, Schweiger LI, Gotthardt LI et al. (1996) Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and in normal comparison subjects. Am J Psychiatry 153:93-99
16. Heuser I, Bisette G, Dettling M et al. (1998) Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin,and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment. Depress Anxiety 8:71-79
17. Holsboer F (1999) The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J Psychiatr Res 33:181-214
18. Holsboer F (2000) The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23:477-501
19. Holsboer F, von Bardeleben U, Gerken A, Stalla GK, Müller OA (1984) Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. N Engl J Med 1984:1127
20. Holsboer F, von Bardeleben U, Wiedemann K, Müller OA, Stalla GK (1987) Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression [arrowhorizex]lmplications for pathophysiology of DST nonsuppression. Biol Psychiatry 22:228-234
21. Holsboer F, von Bardeleben U, Buller R, Heuser I, Steiger A (1987) Stimulation response to corticotropin-releasing hormone (CRH) in patients with depression alcoholism and panic disorder. Horm Metab Res 19:80-88
22. Holsboer F, Barden N (1996) Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocrinol Rev 17:187-205, 1996.
23. Jolkonen J, Lepola LI, Bissette G, Nemeroff C, Riekkinen P (1987) CSF corticotropin-releasing factor is not affected in panic disorder. Biol Psychiatry 33:136-138
24. Kathol RG, Noyes R, Lopez AL, Reich JH (1988) Relationship of urinary free cortisol levels in patients with panic disorder to symptoms of depression and agoraphobia. Psychiatry Res 24:211-221
25. Kellner M, Wiedemann K, Holsboer F (1982) ANF inhibits the CRH-stimulated secretion of ACTH and cortisol in man. Life Sci 50:1835-1842
26. Kellner M, Herzog L, Holsboer F, Wiedemann K (1995) A possible role of atrial natriuretic hormone in pituitary-adrenocortical unresponsiveness in lactate-induced panic. Am J Psychiatry 152:1365-1367
27. A benzodiazepine receptor binding in panic disorder. Arch Gen Psychiatry 47:917-925
28. Modell S, Lauer CJ, Schreiber W, Huber J, Krieg J-C, Holsboer F (1998) Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders. Neuropsychopharmacology 18:253-262
29. Murphy BEP, Filipini D, Ghardirian AM (1993) Possible use of glucocorticoid receptor antagonists in the treatment of major depression: Preliminary results using RU486. J Psychiatry Neurosci 18:209-213
30. Nemeroff CB, Bisette G, Akil H, Fink M (1991) Neuropeptide concentrations in the CSF of depressed patients treated with electroconvulsive therapy. Br J Psychiatry 158:59-63
31. Nutt DJ, Glue P, Lawson C, Wilson S (1990) Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder. Arch Gen Psychiatry 47:917-925
32. O'Dwyer AM, Lightman SL, Marks M, Checkley SA (1995) Treatment of major depression with metyrapone and hydrocortisone. J Affect Disord 33:123-128
33. Patchev VK, Montkowski A, Rouskova D, Koranyi L, Holsboer F, Almeida O (1997) Neonatal treatment of rats with the neuroactive steroid tetrahydrodeoxycorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life events. J Clin Invest 99:962-966
34. Patchev VK, Hassan AH, Holsboer F, Almeida OFX (1996) The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology 15:533-540
35. Paul SM, Purdy RH (1992) Neuroactive steroids. FASEB J 6:2311-2322
36. Reul JMHM, Stec I, Söder M, Holsboer F (1993) Chronic treatment of rats with the antide-pressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology 133:312-320
37. Romeo E, Ströhle A, di Michele F et al. (1998) Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry 155:910-913
38. Roy-Byrne PP, Uhde TW, Post RM, Gallucci W, Chousos GP, Gold PW (1986) The corticotropin-releasing hormone stimulation test in patients with panic disorder. Am J Psychiatry 143:896-899
39. Rubin RT, Phillips JJ, Sado TF, McCracken JT (1995) Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment. Arch Gen Psychiatry 52:213-218
40. Rupprecht R, Ströhle A, Hermann B et al. (1998) Neuroactive steroid concentrations following metyrapone administration in depressed patients and healthy volunteers. Biol Psychiatry 44:912-914
41. Rupprecht R, Holsboer F (1999) Neuroactive steroids: Mechanisms of action and neuropsy-chopharmacological perspectives. Trends Neurosci 22:410-416
42. Schatzberg AF, Rothschild AJ, Langlais PJ, Bird ED, Cole JO (1984) A corticosteroid/dopamine hypothesis for psychotic depression and related states. J Psychiatric Res 19:57-64
43. Schreiber W, Lauer CJ, Krumrey K, Holsboer F, Krieg JC (1996) Dysregulation of the hypothalamic-pituitary-adrenocortical system in panic disorder. Neuropsychopharmacology 15:7-15
44. Stenzel-Poore MP, Heinrichs SC, Rivest S, Koob GF, Vale WW (1994) Overproduction of corticotropin-releasing factor in transgenic mice: A genetic model of anxiogenic behavior. J Neurosci 14:2579-2584
45. Ströhle A, Jahn H, Montkowski A et al. (1997) Central and peripheral administration of atriopeptin is anxiolytic in rats. Neuroendocrinology 65:210-215
46. Ströhle A, Kellner M, Holsboer F, Wiedemann K (1998) Atrial natriuretic hormone decreases endocrine response to a combined dexamethasone corticotropin-releasing hormone test. Biol Psychiatry 43:371-375
47. Ströhle A, Kellner M,Yassouridis A, Holsboer F, Wiedemann K (1998) Effect of flumazenil in lactate-sensitive patients with panic disorder. Am J Psychiatry 155:610-612
48. Ströhle A, Kellner M, Holsboer F, Wiedemann K (1999) Behavioral, neuroendocrine and cardiovascular response to flumazenil: No evidence for an altered benzodiazepine receptor sensitivity in panic disorder. Biol Psychiatry 45:321-326
49. Ströhle A, Romeo E, Hermann B et al. (1999) Concentrations of 3α-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biol Psychiatry 45:274-277
50. Ströhle A, Kellner M, Holsboer F, Wiedemann K (2001) Anxiolytic activity of atrial natriuretic peptide in patients with panic disorder. Am J Psychiatry 158:1514-1516
51. A receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment. Am J Psychiatry 159:145-147
52. A receptor modulatory neuroactive steroid composition in patients with panic disorder. Arch Gen Psychiatry 60:161-168
53. Timpl P, Spanagel R, Sillaber I et al. (1998) Impaired stress response and reduced anxiety in mice lacking a functional corticotropinreleasing homone receptor 1. Nature Genet 19:162-166
54. Uzunov DP, Cooper TB, Costa E, Guidotti A (1996) Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc Natl Acad Sci USA 93:12599-12604
55. Uzunova V, Sheline Y, Davis JM, Rasmusson A, Uzunov DP, Costa E,Guidotti A (1998) Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci USA 95:3239-3244
56. Vale W, Spiess J, Rivier C, Rivier J (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphine. Science 213:1394-1397
57. Wiedemann K, Jahn H, Yassouridis A, Kellner M (2001) Anxiolytic activity of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks. Arch Gen Psychiatry 58:371-377
58. Wolkowitz OM, Reus VI, Chan T, Manfredi F, Raum W, Johnson R, Canick J (1999) Antiglucocorticoid treatment of depression: Double blind ketokonazole. Biol Psychiatry 45:1070-1074
59. Woods SW, Charney DS, McPherson CA, Gradman AH, Heninger GR (1987) Situational panic attacks-Behavioral, physiologic, and biochemical characterization. Arch Gen Psychiatry 44:365-375
60. Yehuda R, Boisneau D, Mason JW, Giller EL (1993) Relationship between lymphocyte glucocorticoid receptor number and urinary free cortisol excretion in mood, anxiety, and psychotic disorder. Biol Psychiatry 34:18-25
61. Yehuda R, Soutwick SM, Krystal JH, Bremner D, Charney DS, Mason JW (1993) Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am J Psychiatry 150:83-86
62. Zobel A, Nickel T, Sonntag A, Uhr M, Holsboer F, Ising M (2001) Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression: A prospective study. J Psychiatr Res 35:83-94
63. Zobel AW, Nickel T, Künzel HE, Ackl N, Sonntag A, Ising M, Holsboer F (2000) Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: The first 20 patients treated. J Psychiatr Res 34:171-181